Analysis Raysearch Laboratories AB (RSLBF)
6/4/2024
Analysis of Raysearch Laboratories AB (RSLBF)
Raysearch Laboratories AB (RSLBF) has shown a consistent increase in the closing price over the past few days, reaching 14.54 on June 3rd. The Relative Strength Index (RSI) is indicating overbought conditions, with a value of 97.12, suggesting a possible reversal or correction in the near future.The Moving Average Convergence Divergence (MACD) indicator is showing a positive trend, with the MACD line above the signal line and a positive MACD histogram. This indicates bullish momentum in the stock.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, supporting the bullish outlook for RSLBF.
Overall, based on the technical indicators, RSLBF seems to be in a strong bullish phase. However, investors should be cautious of the overbought RSI levels and consider the possibility of a correction in the short term.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage held by institutions. The stock price summary shows the stock's performance over the past year, with details on beta, moving averages, and the 52-week range.
Valuation metrics reveal the company's price-to-earnings ratios, enterprise value, price-to-book ratio, and other key financial indicators. The market capitalization is also provided.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split data. This data provides insights into the company's financial health, stock performance, and investor returns.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in revenue, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The company's EBITDA has also been increasing, indicating improved operational efficiency and profitability.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years.
5. The company has been able to maintain a healthy gross profit margin, with gross profit increasing along with revenue.
6. Operating income has also shown a positive trend, reflecting effective cost management and operational performance.
7. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing revenue and profitability indicators.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates has increased to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the estimates suggest a moderate but steady growth in sales for both the upcoming quarters and the fiscal years, with a more significant increase expected in the next fiscal year. The increasing number of analysts providing estimates may indicate growing interest and attention from the investment community in the company's performance.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate for the next year is expected to increase to 9.7%.
5. Past 5 Years (per annum): Over the past 5 years, the company has shown a growth rate of approximately 20.1% per annum.
6. Next 5 Years (per annum): Looking ahead, analysts project a growth rate of around 9.7% per annum for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rates expected in the upcoming periods compared to the current and past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end of the forecast at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which falls below the average and median forecasted prices. Investors may consider these forecasts when making decisions about buying or selling the security.
MACD of RSLBF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
